A geospatial analysis of hotspots and targeted injection settings pilot intervention for HIV prevention among people who inject drugs in Baltimore, Maryland
对马里兰州巴尔的摩注射吸毒者的艾滋病毒预防热点地区和有针对性的注射设置试点干预进行地理空间分析
基本信息
- 批准号:10079583
- 负责人:
- 金额:$ 78.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS preventionAcute Hepatitis CAddressAreaBaltimoreBaseline SurveysBehaviorBehavioralCaringCensusesCessation of lifeCharacteristicsCitiesCluster randomized trialComputer softwareDataEcological momentary assessmentEducationEnsureEquipmentGeographic LocationsGoalsHIVHIV InfectionsHIV SeronegativityHIV SeropositivityHIV diagnosisHIV drug resistanceHIV riskHIV/HCVHealthHepatitis CHepatitis C AntibodiesHepatitis C TransmissionHigh School StudentHuman immunodeficiency virus testIncidenceInfectionInjecting drug userInjectionsInterventionIntervention TrialLocationMapsMarylandMassachusettsMethodsNaloxoneOnline SystemsOpioidOutcomeOverdoseParticipantPatient Self-ReportPharmaceutical PreparationsPreventionPrivatizationRandomizedRecording of previous eventsResearchRiskRisk BehaviorsRisk ReductionSamplingSocial NetworkSupervisionSurveysTechnologyTestingTimeTrainingViral Load resultWashingtonbasecookingevidence basehigh riskhigh risk behaviorimprovedindexinginjection drug useinnovationmortalitynovelnovel strategiesopioid injectionopioid overdoseoverdose preventionoverdose riskpeerpreventprogramsrecruitsocialsocial normstandard of caretransmission processtreatment armtrendvirology
项目摘要
Project Summary
This resubmission of application R01DA050470 proposes to use innovative approaches to identify “hotspots,”
defined as geographic areas in which high rates of HIV or HCV infection, high HIV viral loads, or drug-resistant
HIV strains are found. We propose two novel approaches for identifying hotspots: 1) Use of web-based
mapping technology to document observed and self-reported HIV and overdose risk behaviors among PWID in
private and semi-public injection settings (SPIS) and the attributes of these risk settings; 2) Systematically
collect cookers (containers used to mix and heat drugs before injecting) from injection settings and test them
for HIV and HCV antibodies (testing cookers is a novel method developed in the Johns Hopkins Virology lab).
We will recruit 600 HIV positive and negative people who inject drugs (PWID). These PWID will complete a
survey using a software program developed by our team to locate and map the areas where they inject and
attributes of these injection settings. These data will be used to identify high-risk behaviors in SPIS within
census block groups (CBGs). These participants will be followed for 2 years.
The findings from this observational portion of the study will then be used to inform an innovative pilot of an
injection setting targeted peer-driven intervention to reduce HIV/HCV transmission and overdose risk
behaviors. From the identified CBGs, we will select 60 non-contiguous CBGs for a pilot cluster randomized trial
(CRT) of the intervention. The CBGs will be randomized to one of 4 conditions: 1) Peer education and stocking
of SPIS with risk reduction materials, 2) Peer education only, 3) Stocking SPIS with risk reduction materials
only, and 4) The standard of care. Based on their CBG and SPIS use, 120 index PWID participants will be
selected from the 600 PWID. These index participants will receive training corresponding to the assigned
condition of their CBG. The indexes will implement the intervention targeting two specific SPIS. Each index will
also recruit PWID from their CBG to serve as data collectors. In the SPIS, the data collectors will use
Ecological Momentary Assessment (EMA) and collect cookers for HIV/HCV testing. Data from the indexes
(N=120) and data collectors (N=120) will be used as outcomes of the 4-arm intervention.
项目摘要
申请R01DA 050470的重新提交提议使用创新方法来识别"热点",
定义为HIV或HCV感染率高、HIV病毒载量高或耐药的地理区域
我们提出了两种识别热点的新方法:1)使用基于网络的
映射技术,以记录观察到的和自我报告的艾滋病毒和吸毒过量的风险行为,
私人和半公共注射设置(SPIS)和这些风险设置的属性; 2)系统地
从注射场所收集炊具(注射前用于混合和加热药物的容器)并对其进行测试
检测HIV和HCV抗体(测试炊具是约翰霍普金斯病毒学实验室开发的一种新方法)。
我们将招募600名艾滋病毒阳性和阴性的注射毒品者。这些PWID将完成
使用我们团队开发的软件程序进行调查,以定位和绘制他们注入的区域,
这些进样设置的属性。这些数据将用于识别SPIS中的高风险行为,
人口普查区块组(CBG)。这些参与者将被随访2年。
这项研究的观察部分的结果将用于告知创新飞行员,
注射设置有针对性的同行驱动的干预,以减少艾滋病毒/丙型肝炎病毒的传播和过量的风险
行为。从确定的CBG中,我们将选择60个非连续CBG进行试点随机分组试验
(CRT)的干预。CBG将被随机分配到4个条件之一:1)同伴教育和放养
2)仅进行同伴教育,3)为SPIS储备风险降低材料
(4)护理标准。根据CBG和SPIS的使用情况,将有120名指数PWID参与者
从600 PWID中选择。这些索引参与者将接受与分配的
他们的CBG。这些指数将针对两个特定的SPIS实施干预措施。每个索引将
还从CBG招募PWID作为数据收集员。在SPIS中,数据收集器将使用
生态瞬时评估(EMA)和收集炊具进行艾滋病毒/丙型肝炎病毒检测。来自指数的数据
(N = 120)和数据收集器(N = 120)将用作4组干预的结局。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CARL A LATKIN其他文献
CARL A LATKIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CARL A LATKIN', 18)}}的其他基金
A social diffusion fatal overdose prevention intervention: Assessing the effectiveness of people who use opioids as peer educators in training using & non-using networks on overdose & stigma reduction
社会扩散致命过量预防干预措施:评估使用阿片类药物的人作为同伴教育者在培训中的有效性
- 批准号:
10716356 - 财政年份:2023
- 资助金额:
$ 78.45万 - 项目类别:
A social network approach for improving medication assisted treatment and HIV prevention and medical care among people who inject drugs in Ukraine
用于改善乌克兰注射吸毒者的药物辅助治疗、艾滋病毒预防和医疗保健的社交网络方法
- 批准号:
10676829 - 财政年份:2021
- 资助金额:
$ 78.45万 - 项目类别:
A social network approach for improving medication assisted treatment and HIV prevention and medical care among people who inject drugs in Ukraine
用于改善乌克兰注射吸毒者的药物辅助治疗、艾滋病毒预防和医疗保健的社交网络方法
- 批准号:
10491775 - 财政年份:2021
- 资助金额:
$ 78.45万 - 项目类别:
A social network approach for improving medication assisted treatment and HIV prevention and medical care among people who inject drugs in Ukraine
用于改善乌克兰注射吸毒者的药物辅助治疗、艾滋病毒预防和医疗保健的社交网络方法
- 批准号:
10321719 - 财政年份:2021
- 资助金额:
$ 78.45万 - 项目类别:
A geospatial analysis of hotspots and targeted injection settings pilot intervention for HIV prevention among people who inject drugs in Baltimore, Maryland
对马里兰州巴尔的摩注射吸毒者的艾滋病毒预防热点地区和有针对性的注射设置试点干预进行地理空间分析
- 批准号:
10402888 - 财政年份:2020
- 资助金额:
$ 78.45万 - 项目类别:
A geospatial analysis of hotspots and targeted injection settings pilot intervention for HIV prevention among people who inject drugs in Baltimore, Maryland
对马里兰州巴尔的摩注射吸毒者的艾滋病毒预防热点地区和有针对性的注射设置试点干预进行地理空间分析
- 批准号:
10203907 - 财政年份:2020
- 资助金额:
$ 78.45万 - 项目类别:
Health disparities, stress pathways, and stress-related comorbidities among MSM living with HIV
HIV 感染者中 MSM 的健康差异、压力途径和压力相关合并症
- 批准号:
9651006 - 财政年份:2018
- 资助金额:
$ 78.45万 - 项目类别:
Health disparities, stress pathways, and stress-related comorbidities among MSM living with HIV
HIV 感染者中 MSM 的健康差异、压力途径和压力相关合并症
- 批准号:
10364643 - 财政年份:2018
- 资助金额:
$ 78.45万 - 项目类别:
Health disparities, stress pathways, and stress-related comorbidities among MSM living with HIV
HIV 感染者中 MSM 的健康差异、压力途径和压力相关合并症
- 批准号:
9765389 - 财政年份:2018
- 资助金额:
$ 78.45万 - 项目类别:
Health disparities, stress pathways, and stress-related comorbidities among MSM living with HIV
HIV 感染者中 MSM 的健康差异、压力途径和压力相关合并症
- 批准号:
9892889 - 财政年份:2018
- 资助金额:
$ 78.45万 - 项目类别:
相似海外基金
Biomarkers of spontaneous acute hepatitis C virus resolution
自发性急性丙型肝炎病毒消退的生物标志物
- 批准号:
8262303 - 财政年份:2012
- 资助金额:
$ 78.45万 - 项目类别:
Biomarkers of spontaneous acute hepatitis C virus resolution
自发性急性丙型肝炎病毒消退的生物标志物
- 批准号:
8458955 - 财政年份:2012
- 资助金额:
$ 78.45万 - 项目类别:
Baltimore Acute Hepatitis C Cooperative Center
巴尔的摩急性丙型肝炎合作中心
- 批准号:
8625266 - 财政年份:2010
- 资助金额:
$ 78.45万 - 项目类别:
Mechanisms of repeated control of acute hepatitis C infection in humans
反复控制人类急性丙型肝炎感染的机制
- 批准号:
9900734 - 财政年份:2010
- 资助金额:
$ 78.45万 - 项目类别:
Baltimore Acute Hepatitis C Cooperative Center
巴尔的摩急性丙型肝炎合作中心
- 批准号:
8445240 - 财政年份:2010
- 资助金额:
$ 78.45万 - 项目类别:
Baltimore Acute Hepatitis C Cooperative Center
巴尔的摩急性丙型肝炎合作中心
- 批准号:
8240544 - 财政年份:2010
- 资助金额:
$ 78.45万 - 项目类别:
Baltimore Acute Hepatitis C Cooperative Center
巴尔的摩急性丙型肝炎合作中心
- 批准号:
8054921 - 财政年份:2010
- 资助金额:
$ 78.45万 - 项目类别:
Mechanisms of repeated control of acute hepatitis C infection in humans
反复控制人类急性丙型肝炎感染的机制
- 批准号:
9246424 - 财政年份:2010
- 资助金额:
$ 78.45万 - 项目类别:
Baltimore Acute Hepatitis C Cooperative Center
巴尔的摩急性丙型肝炎合作中心
- 批准号:
7912185 - 财政年份:2010
- 资助金额:
$ 78.45万 - 项目类别:
Mechanisms of repeated control of acute hepatitis C infection in humans
反复控制人类急性丙型肝炎感染的机制
- 批准号:
9098149 - 财政年份:2010
- 资助金额:
$ 78.45万 - 项目类别:














{{item.name}}会员




